Microdeletions of the MEF2C gene are linked to a syndromic form of autism termed MEF2C 2 haploinsufficiency syndrome (MCHS). Here, we show that MCHS-associated missense mutations cluster 3 in the conserved DNA binding domain and disrupt MEF2C DNA binding. DNA binding-deficient global 4 Mef2c heterozygous mice (Mef2c-Het) display numerous MCHS-like behaviors, including autism-related 5 behaviors, as well as deficits in cortical excitatory synaptic transmission. We find that hundreds of genes 6 are dysregulated in Mef2c-Het cortex, including significant enrichments of autism risk and excitatory 7 neuron genes. In addition, we observe an enrichment of upregulated microglial genes, but not due to 8 neuroinflammation in the Mef2c-Het cortex. Importantly, conditional Mef2c heterozygosity in forebrain 9 excitatory neurons reproduces a subset of the Mef2c-Het phenotypes, while conditional Mef2c 10 heterozygosity in microglia reproduces social deficits and repetitive behavior. Together our findings 11 suggest that MEF2C regulates typical brain development and function through multiple cell types, 12 including excitatory neuronal and neuroimmune populations.
communications), several frameshift and premature stop codon mutations were identified -all of which, 1 if stable, are predicted to produce a truncated MEF2C protein lacking its C-terminal nuclear localization 2 sequence. We also noted that all of the MEF2C missense (or small duplication) mutations were clustered 3 within the highly-conserved MADS (DNA binding) or MEF2 (dimerization) domains (Fig. 1A) . In a MEF2 4 response element DNA binding assay, all five of the MADS domain patient mutations caused a loss of 5 MEF2C DNA binding ( Fig. 1B-C, S1A) , and they did not appear to interfere with wild-type MEF2C DNA 6 binding ( Fig. S1B ), suggesting a loss-of-function phenotype. To model the genetics of MCHS in mice, we generated a global heterozygous Mef2c mutant 10 mouse lacking exon 2 (Mef2c +/DEx2 or Mef2c-Het) (Fig. 1D ), which encodes a large portion of the 11 MADS/MEF2 domains. The near full-length MEF2C DEx2 protein had no detectable DNA binding affinity 12 and did not reduce DNA binding affinity of wild-type MEF2C expressed at a similar level ( Fig. 1E -F, S1C).
13
We observed a non-Mendelian frequency of Mef2c-Hets, suggesting a partial embryonic lethality 14 (Extended Data Fig. 1D , **p<0.01, Chi-square test), similar to a previous report (Tu et al., 2017) .
15
We examined whether male and female Mef2c-Het mice showed behavior phenotypes 16 reminiscent of MCHS symptoms. Using a three-chamber social interaction (SI) test, we observed that 17 Mef2c-Het mice have a lack of social preference with a novel same-sex mouse ( Fig. 2A , *p<0.05, 2-way 18 ANOVA). We also found that Mef2c-Het male and female pups (P7-P10) produced significantly fewer 19 ultrasonic vocalization (USV) calls during maternal separation ( Fig. 2B , main effect of genotype, 20 **p<0.01), and young adult Mef2c-Het males produced significantly fewer USV calls (Fig. 2C , *p<0.05) 21 in the presence of an estrous female, suggesting that Mef2c-Hets have deficits in a putative species-22 appropriate form of social communication. Male Mef2c-Hets were hyperactive in a novel environment 23 ( Fig. 2E , ***p<0.005) and displayed an increase in jumping ( Fig. 2F , *p<0.05), a repetitive-type motor 24 behavior; however, young adult Mef2c-Hets displayed normal performance on the accelerating rotarod 25 test of motor coordination (Fig. 2D ). In addition, Mef2c-Hets showed increased exploration of the open, 26 unprotected arm of the elevated plus maze (Fig. 2G ). High pain tolerance is also frequently reported in 27 MCHS individuals (Paciorkowski et al., 2013; Zweier et al., 2010) . Interestingly, Mef2c-Het mice showed reduction in pre-and/or postsynaptic transmission. Paired-pulse facilitation (PPF) analysis (50 ms 1 interstimulus interval) of local horizontal inputs revealed a significant increase in PPF ratio (Fig. 3C ), 2 indicating a decrease in presynaptic release probability (Fioravante and Regehr, 2011) . These effects 3 were input-selective given that electrical stimulation of layer 4 (within the same cortical column) produced 4 eEPSC and PPF responses in layer 2/3 neurons that were indistinguishable from controls (Fig. 3D ). To 5 examine if reductions in AMPA-mediated postsynaptic strength might also contribute to the reduced 6 horizontal eEPSCs (Fig. 3C ), we measured miniature EPSCs (mEPSCs) under conditions where action 7 potentials are blocked pharmacologically. In layer 2/3 cells from Mef2c-Hets, we observed a significant 8 reduction in mEPSCs amplitude ( Fig. 3E ), suggesting an overall reduction in AMPA-mediated 9 postsynaptic strength. Similar to layer 2/3, we also observed a significant reduction of mEPSC amplitude 10 in SSCtx layer 5 pyramidal neurons of Mef2c-Hets (Fig. 3F ), suggesting that the reduction in 11 glutamatergic postsynaptic strength is not limited to a specific cortical layer. Consistent with layer 2/3 12 pyramidal neurons, we did not observe any differences in dendritic spine density or dendritic spine head 13 diameter in basal dendrites from layer 5 pyramidal neurons (Fig. S3C ). There was no effect of genotype 14 on layer 5 mEPSC frequency (Fig. 3F ), but we observed a significant increase in the layer 2/3 mEPSCs 15 frequency ( Fig. 3E ) that was not explained by an increase in dendritic spine density (Fig. S3B ) or effects 16 on presynaptic functions of local inputs (Fig. 3C,D) , and might represent a compensatory effect of long-17 range connections (Rajkovich et al., 2017) .
19
Mef2c-Het mice display dysregulation of cortical genes associated with ASD risk, excitatory 20 neurons and microglia 21 Using an unbiased RNA-sequencing (RNA-Seq) approach, we examined gene expression from 22 whole cortex in control and Mef2c-Hets (p35-p40), and we identified 490 genes that were significantly 23 dysregulated (FDR < 0.05; Fig. 4A , S4A; Table S1,S2). We confirmed the differential expression of a 24 number of interesting Mef2c-Het differentially expressed genes (DEGs) that are associated with ASD 25 risk, microglia, and others by qRT-PCR ( Fig. 4D ). We also investigated the association of Mef2c-Het 26 DEGs with genetic and genomic data from various brain disorders. We found that the Mef2c-Het DEGs, 27 particularly the downregulated genes, were overrepresented in genes associated with ASD risk and FMRP binding ( Fig. 4B ; Table S1 ; Fig. 4D ). We also assessed enrichment for Mef2c-Het DEGs in genes 1 that are dysregulated in a meta-analysis of transcriptomic data across neuropsychiatric disorders (Gandal 2 et al., 2018) . Interestingly, Mef2c-Het DEGs, particularly the downregulated genes, were significantly 3 enriched for a PsychENCODE excitatory neuron module of genes that are downregulated in ASD (versus 4 other neuropsychiatric disorders) brains (geneM1; Fig. 4C ; Table S2 ). We also observed significant 5 enrichment of Mef2c-Het DEGs in PsychENCODE gene module 8 (geneM8; Fig. 4C ; Table S2 ), which is 6 an excitatory neuron module of genes downregulated in both ASD and schizophrenia and enriched for 7 Bipolar Disorder (BPD) genetic variants. Mef2c-Het DEGs, particularly the upregulated genes, were 8 enriched in PsychENCODE module 6, which is a microglia module of genes upregulated in ASD, but 9 downregulated in SCZ and BPD (geneM6; Fig. 4C ; Table S2 ). Using single-cell RNA-seq data from 10 mouse cortex (Saunders et al., 2018) , we observed that Mef2c-Het DEGs were strongly enriched for 11 cortical excitatory neuron genes and microglia genes ( Fig. S4B ; Table S2 ), further supporting the 12 importance of MEF2C in regulating gene expression in the two key brain populations where MEF2C 13 expression is most highly expressed.
14 Gene ontology analysis of the Mef2c-Het DEGs revealed significant enrichment of microglia 15 proliferation genes, cell metabolism genes, and genes in a microglia subpopulation in the developing 16 brain that is restricted to unmyelinated axon tracts ( Fig. S5 ). Since Mef2c-Hets showed significant 17 dysregulation of microglial genes ( Fig. 4C,D) , and MEF2C is expressed in microglia in the developing 18 and mature brain ( Fig. S5 ) (Deczkowska et al., 2017; Gosselin et al., 2017; Zhang et al., 2014a) , we 19 analyzed the Mef2c-Het brain for possible upregulation of the microglia cell-type and neuroimmune 20 activation marker, ionized calcium-binding adapter molecule 1 (Iba1) (Ito et al., 1998; Ito et al., 2001) . In 21 both the cortex and hippocampus, we observed a significant increase in Iba1 expression ( Fig. 5A -C,E; 22 ****p<0.0001, K-S test) without a change in the density of microglia ( Fig. 5D,F ), suggesting possible 23 microglial activation in the Mef2c-Het brain. This increase in Iba1 was present without an obvious change 24 in microglial cell morphology or microglial cell soma volume (Figs. 5A, B, G) . In addition, in the Mef2c-Het 25 cortex, we observed no changes in classic-and alternative-pathway pro-inflammatory genes, including risk, including C1qb, C1qc and C4b (Fig. 4D, (Bialas and Stevens, 2013; Odell et al., 2005; Schafer et 1 al., 2012; Sekar et al., 2016; Stevens et al., 2007) . Moreover, we observed significant enrichments of 2 upregulated Mef2c-Het DEGs in scRNA-seq gene clusters associated with embryonic-like microglia, 3 postnatal immature microglia, and homeostatic microglia ( Fig. 5H ). Taken together, these results reveal 4 that the reduction of MEF2C levels has significant impacts on microglia gene expression programs. In the developing and mature mouse brain, MEF2C is expressed in several neuronal cell types, 9 including cortical excitatory pyramidal cells and Parvalbumin-positive GABAergic inhibitory neurons, and 10 in microglia (Barbosa et al., 2008; Harrington et al., 2016; Kamath and Chen, 2018; Mayer et al., 2018;  11 Zhang et al., 2014b) . Since the Mef2c-Het mouse cortex showed robust changes in both excitatory 12 neurons and microglia gene expression (Figs. 4, S4), we generated cell type-specific conditional Mef2c 13 heterozygous mice to explore the contribution of forebrain excitatory neurons versus microglia for the 14 development of MCHS-like phenotypes. We first generated mice heterozygous for Mef2c in Emx1-lineage 15 cells (Mef2c-cHet Emx1-cre ) (Iwasato et al., 2008) , which represents ~85% of forebrain excitatory neurons 16 throughout the cortex and hippocampus. Similar to the global Mef2c-Hets, the Mef2c-cHet Emx1-cre mice 17 displayed altered anxiety-like behavior and male-selective increases in locomotion and repetitive jumping 18 ( Fig. 6A -C), but they showed no changes in social behavior or shock sensitivity ( Fig. 6D, S6A ).
Interestingly, similar to global Mef2c-Hets ( Fig. 3E ) and Mef2c cKO Emx1-cre mice (Harrington et al., 2016) ,
20
we observed a reduction of mEPSC amplitude in layer 2/3 pyramidal neurons from Mef2c-cHet Emx1-cre 21 mice ( Fig. S6D ), suggesting that the deficit in cortical glutamatergic synaptic transmission in layer 2/3 of 22 the global Mef2c-Hets is due to MEF2C's function in excitatory forebrain neurons. In addition, mice 23 heterozygous for Mef2c in PV-positive GABAergic interneurons (Mef2c-cHet PV-cre ) -a population of 24 predominantly GABAergic interneurons with high MEF2C expression -also showed male-selective 25 increases in locomotion ( Fig. 6F ), but these mice did not develop changes in repetitive jumping, anxiety-26 like behavior, social interaction, or shock sensitivity (Figs. 6E,G-H, S6B). These findings suggest that 27 Emx1-lineage excitatory forebrain neurons, and to a much lesser extent PV-expressing neurons, contribute to the development of some, but not all, of the behavior phenotypes observed in the global 1 Mef2c-Hets.
2
To explore a possible contribution of MEF2C in microglia to MCHS-like behaviors, we generated 3 mice heterozygous for Mef2c selectively in microglia (Mef2c-cHet Cx3cr1-cre ). The conditional mutant mice 4 displayed social impairments in the 3-chamber social interaction test ( Fig. 6L , *p<0.05, two-way ANOVA), 5 similar to the Mef2c-Het mice. In addition, Mef2c-cHet Cx3cr1-cre mice showed a significant increase in male-6 specific repetitive jumping ( Fig. 6K , *p<0.05, Welch's t-test), but with no discernable effects on exploratory 7 activity ( Fig. 6J ), anxiety-like behavior or shock sensitivity ( Fig. 6I, S6C ). Taken together, our 8 observations suggest that Mef2c haploinsufficiency in early postnatal microglial cells is sufficient to 9 produce autism-related behaviors, and that the majority of MCHS-like phenotypes in the global Mef2c-
10
Hets are a consequence of MEF2C hypofunction in both neurons and microglia.
12

Discussion
13
We report here three new MEF2C mutations identified in individuals with MCHS-related 14 symptoms, and these MEF2C missense or small duplication mutations disrupted MEF2C DNA binding.
15
Interestingly, all of the known MCHS missense or duplication mutations cluster within the highly-16 conserved MADS and MEF2 domains ( Fig. 1A ) that mediate the DNA binding and dimerization functions 17 of MEF2C (McKinsey et al., 2002) . We also found that global, DNA binding-deficient Mef2c heterozygous 18 mice display numerous behavioral phenotypes reminiscent of MCHS, including social interaction deficits, 19 ultrasonic vocalization deficits, motor hyperactivity, repetitive behavior, anxiety-related behavior and 20 reduced sensitivity to a painful stimulus (footshock). The Mef2c-Hets also possessed input-selective pre-21 and postsynaptic deficits in glutamatergic excitatory synaptic transmission in the somatosensory cortex.
22
Gene expression analysis of cortical tissue from Mef2c-Hets revealed significant enrichment of genes 23 linked to ASD risk, excitatory neurons and microglia, which is notable considering the enrichment of Mef2c-Het mice, early postnatal conditional Mef2c heterozygosity in Cx3cr1-lineage cells, which in the 1 brain are almost exclusively microglia (Hoogland et al., 2015; Ito et al., 1998; Ito et al., 2001) , produced 2 offspring with social deficits and increased repetitive behavior. Our findings support the emerging view 3 that microglial dysfunction in the developing brain can contribute to the development of ASD symptoms.
4
While our findings reveal a key role for MEF2C in both neurons and microglia for neurotypical 5 behaviors in mice, there are a number of new questions raised by these findings. For example, why do 6 we see male-selective effects of Mef2c heterozygosity on hyperactivity and/or jumping behavior in the indeed, numerous studies have demonstrated that both neuron and microglia functions can be 10 differentially regulated in males and females (Wright-Jin and Gutmann, 2019) . It is also interesting to note 11 that Mef2c-Het DEGs linked to excitatory neurons show a preferential downregulation, whereas Mef2c-
12
Het DEGs linked to microglia display a preferential upregulation. MEF2C is reported to function as both 13 a transcriptional activator and a repressor, and there are cell type-specific signaling mechanisms that 14 regulate MEF2C activity (Harrington et al., 2016; Kang et al., 2006; Lyons et al., 2012) . Determining 15 whether or how MEF2C regulates cell type-specific gene expression as an activator or repressor, or 16 whether the DEGs are an indirect consequence of MEF2C hypofunction, will be important goals for future 17 studies.
18
MEF2 proteins can regulate activity-dependent glutamatergic synapse elimination (Flavell et al., 19 2006; Pfeiffer et al., 2010; Pulipparacharuvil et al., 2008; Tsai et al., 2012) reward-related behavior, motor hyperactivity and repetitive behaviors, and differential gene expression 26 (Adachi et al., 2015; Barbosa et al., 2008; Harrington et al., 2016; Li et al., 2008) . In contrast to these 27 Mef2c brain conditional knockouts, humans with MCHS possess deletions or mutations in a single gene copy throughout the entire body (Berland and Houge, 2010; Bienvenu et al., 2013; Engels et al., 2009; 1 Le Meur et al., 2010; Mikhail et al., 2011; Novara et al., 2010; Paciorkowski et al., 2013; Tonk et al., 2011;  2 Vrecar et al., 2017; Zweier et al., 2010; Zweier and Rauch, 2012) . Since MCHS symptoms are reported 3 predominantly from macro-and microdeletions that disrupt MEF2C and other neighboring genes, we 4 sought to identify possible loss-of-function MEF2C mutations within its protein coding region to better 5 understand the relationship between symptoms and MEF2C. By comparing multiple new MEF2C-related 6 mutations from individuals with developmental delay and other MCHS-associated symptoms, we 7 observed that all of the missense mutations resided within the MEF2C DNA binding and dimerization 8 domains (MADS/MEF2). In addition, there were multiple mutations that produced a premature stop codon 9 or a frameshift predicted to produce a truncated MEF2C lacking the C-terminal nuclear localization 10 sequence. One interesting observation was the ~1.3-fold increase in Mef2c mRNA levels in the Mef2c-
11
Het mouse cortex ( Fig. 4 ). However, there was a ~50% reduction of the exon 2-containing transcripts 12 (the Cre-flox edited exon), resulting in ~35% overall reduction in full-length, functional MEF2C ( Fig. 4D ).
13
This suggests that MEF2C might negatively regulate its own gene expression, as originally reported in 14 muscle cells (Wang DZ et al., 2001) , and that a relatively modest overall reduction in MEF2C levels is 15 sufficient to produce numerous changes in gene expression, synaptic development and function, and 16 neurotypical behaviors.
17
Developing and mature microglia play important roles in brain development, including synaptic 18 phagocytosis (Paolicelli et al., 2011; Schafer et al., 2012) . Microglia also mediate synapse patterning, 19 neurogenesis, myelinogenesis, and cellular phagocytosis (Parkhurst et al., 2013; Sierra et al., 2010; Zhan 20 et al., 2014) . MEF2C is expressed in both human and mouse microglia, and MEF2 proteins regulate 
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S4), and we find that Mef2c hypofunction in microglia (Cx3cr1-lineage) is sufficient to produce autism-24 like behaviors in mice ( Fig. 6K,L) . Interestingly, despite a strong increase in the Mef2c-Het brain of the Mef2c copy does not produce classic microglial "activation", but rather that microglial development, 1 function or maturation might be perturbed. Of note, Mef2c-Het DEGs showed enrichment for a scRNA-2 seq cluster of genes associated with embryonic and immature postnatal microglia, suggesting a possible 3 delay in microglia maturation in the Mef2c-Het mice. Future studies will be important to determine the 4 precise roles of MEF2C in microglial development and function, and whether Mef2c heterozygosity alters 5 one or more of the numerous reported roles for microglia in brain development.
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Data are reported as mean ± SEM. Also see Figure S1 . 19 
GGCAGAGAACCATGGCCCAGAA AATCGATGACAGCGCCTCAGCC Patients with developmental delay and a significant variant in the MEF2C gene were selected for this 3 study. These patients were seen for clinical genetics evaluations and data from these visits were gathered 4 from records review. Internal informed consent to publish data was obtained for each subject. 
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(Avisoft Bioacoustics) using a 20 kHz cutoff. Distress USVs were recorded from juvenile mice (pups) as previously described (Ey et al., 2013; Harrington et al., 2016; Scattoni et al., 2008) . Briefly, individual pups 1 of both sexes were identified with long-lasting subcutaneous tattoos (green tattoo paste; Ketchum) on 2 the paws on post-natal day 4 (P4). Pups of both sexes were recorded in a random order in a small, 3 sound-attenuated chamber following separation from dam and littermates. USVs were recorded for 3 4 minutes on post-natal days 7 and 10. USVs were quantified using Avisoft SASLab Pro (Avisoft 
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terminates with a 2-second mild foot-shock (0.5 mA) was presented to the animal. The mice were 26 exposed to 3 tone/shock pairing with a 1-minute interval separating each tones/shock. The next day,
27
animals were returned to the chamber and behavior (freezing) in the context, in a new context, and with the audible tone played in a new context is recorded with a video-tracking system (Video Freeze V2.7;
1 Med Associates). Data are presented as percent of time the mouse is immobile.
3
Barnes Maze: Barnes maze was conducted as previously described (Rosenfeld and Ferguson, 2014) 4 with modifications. Briefly, on the initial trial, mice were acclimated to the escape chamber for 2 minutes 5 before testing. During testing, mice were introduced to the center of the Barnes Maze (Stoelting #60170) 6 in bright white light (250 or 450 lux) with 4 distinct spatial cues evenly distributed around the arena. Mice 7 were allowed to freely explore the arena for 5 minutes or until the mice found and entered the escape 8 chamber. Latency to escape was recorded for each trial. Mice failing to find the escape chamber at the 9 end of the trial were guided to the escape hole. All mice were left in the escape chamber for 2 minutes 10 before being returned to their home cage. Each mouse was tested twice a day, and data reflect the 11 average latency to enter the escape hole of the 2 trials per day. 20 minutes before objects were introduced. Mice were presented with 2 identical objects located on opposite 21 sides of the OF arena and allowed to explore the objects for 10 minutes. One initial object was replaced 22 with a novel object, and the mice were allowed to explore the objects for 10 minutes. Mice were recorded 23 and analyzed using ANY-maze behavior tracking software (Stoelting). Interactions were considered when 24 the center of the mouse was within 8 cms from the center of the object.
26
Sucrose preference: Test mice were singly housed and provided 2 identical ball-bearing sipper-style 27 bottles to drink. Mice were acclimated to the 2 bottles for 4 days, where both bottles contained water on days 1 and 3 or sucrose solution on days 2 and 4. On days 5-8, mice were presented with 2 bottles, one 1 with water and one with sucrose (1% (w/v)). Daily, the consumption of water and sucrose/quinine was 2 measured, and the bottle position was altered to avoid potential side bias (Renthal et al., 2007) . Data is 3 presented as (solution consumption -water consumption) / total consumption = Preference Index.
5
Sucrose Self-Administration (SSA): Sucrose self-administration (SA) was performed as previously 6 described (Taniguchi et al., 2017) . Briefly, mice were introduced to an operant conditioning chamber (Med 7 Associates) at the same time each day during the dark cycle (active-phase). Both a light above the active 8 nose poke hole and the house light indicated that sucrose was available. After an active hole nose poke, 9 the availability lights went off and an internal light in the nose poke hole was activated. Active nose pokes 10 immediately delivered a sucrose pellet (15 mg; TestDiet) and was followed by a 10 s time-out period.
11
Inactive hole nose pokes did not have any consequences. After 12 days of acquiring, the mice entered a 12 7-day abstinence phase in their home cages and were not exposed to the operant conditioning chamber.
13
Following abstinence, the mice were placed back in the operant chamber for 2 hours, where the sucrose 14 pellets and cues were not present. Following 7 days of extinction, mice were re-introduced to the operant 15 chamber and the availability cues and reward delivery cue (but no sucrose reward) were presented (cue- startle, mice were exposed to 5 white-noise pulses/amplitude (38ms) at 3 different amplitudes (70, 80, 27 90 dB) in a randomized order with variable inter-trial intervals (10-20s). Displacements of the load cell 28 stabilimeter were converted into arbitrary units by an analog-to-digital converter interfaced to a personal 1 computer.
3
RNA Isolation and Reverse Transcription PCR. Cortical tissue from p35-p40 mice (2 males and 2 4 females per genotype) were rapidly dissected and frozen at -80°C. Samples were thawed in TRIzol 5 (Invitrogen), homogenized, and processed using the miRNeasy Mini Kit (Qiagen) according to 6 manufacturer's protocol. Total RNA was reverse-transcribed using Superscript III (Invitrogen) with 7 random hexamers following manufacturer's protocol. Quantitative real-time PCR was performed by the 8 CFX96 qPCR instrument (Bio-Rad) using iTaq Universal SYBR Green Supermix (Bio-Rad) and primers 9 specific to each target gene (Table S3 ). GAPDH was used to normalize gene expression in each sample.
10 11 RNA Sequencing. Total RNA was isolated from whole cortex of p35-p40 mice as described above.
12
Sequencing was performed by BGI Americas Corporation (Cambridge, MA) using polyA mRNA isolation,
13
directional RNA-seq library preparation, and the BGISEQ-500 platform with 150bp paired-end reads unmapped reads that spanned splice junctions was produced. Secondary alignment and multi-mapped 21 reads were further removed using in-house scripts. Only uniquely mapped reads were retained for further 22 analyses. Quality control metrics were performed using RseqQC using the m10 gene model provided.
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These steps include: number of reads after multiple-step filtering, ribosomal RNA reads depletion, and 24 defining reads mapped to exons, UTRs, and intronic regions. Picard tool was implemented to refine the 25 QC metrics (http://broadinstitute.github.io/picard/). Genecode annotation for mm10 (version M21) was 26 used as reference alignment annotation and downstream quantification. Gene level expression was calculated using HTseq version 0.9.1 using intersection-strict mode by gene (Anders et al., 2015) . Counts 1 were calculated based on protein-coding genes from the annotation file. Fitting this model, we estimated log2 fold changes and P-values. P-values were adjusted for multiple
